ctDNA in Pancreatic and Colorectal Cancer

How ctDNA testing is being investigated and used in pancreatic and colorectal cancer in the era of precision medicine.

EP. 1: MRD Testing in Solid Tumors

February 15th 2022

The present role of minimal residual disease in solid tumor cancers, and current evaluations further exploring its potential in pancreatic and colorectal cancer.

EP. 2: Potential Applications of ctDNA Testing in Colorectal Cancer

February 15th 2022

An overview of the ctDNA testing platforms and the potential clinical applications of ctDNA testing across the colorectal cancer disease continuum.

EP. 3: ctDNA Testing in Pancreatic Cancer

February 22nd 2022

The potential clinical applications of ctDNA analyses in pancreatic cancer.

EP. 4: Preoperative and Postoperative ctDNA Testing in Colorectal Cancer

February 22nd 2022

How ctDNA testing can be used in the preoperative and postoperative settings to help oncologists make informed treatment decisions.

EP. 5: Personalized/Tumor-Informed ctDNA and Patient Survival in Pancreatic Cancer

March 1st 2022

Dr Gregory P. Botta reacts to results of a study that recently explored the association of tumor-informed and personalized ctDNA with patient survival outcomes in pancreatic cancer, as presented at ASCO GI 2022.

EP. 6: Earlier Detection of Relapse in Colorectal Cancer

March 1st 2022

Key takeaways of a recent article highlighting the use of ctDNA analyses for the assessment of recurrence risk, benefit of adjuvant therapy, and early relapse detection after treatment in colorectal cancer patients.

EP. 7: Future Role of ctDNA in Pancreatic Cancer

March 8th 2022

Current trials investigating the potential of ctDNA analyses in pancreatic cancer.

EP. 8: Updated Results of CIRCULATE-Japan in Colorectal Cancer

March 8th 2022

Implications of the GALAXY study in CIRCULATE-Japan, in terms of utilizing ctDNA to guide decisions for adjuvant chemotherapy in colorectal cancer.

EP. 9: CIRCULATE-Japan: Using ctDNA to Guide Adjuvant Therapy in Colorectal Cancer

March 15th 2022

What to know about the design and results of the CIRCULATE-Japan study in colorectal cancer, in terms of using ctDNA analyses to help inform treatment decisions in the postoperative setting.

EP. 10: Objectives of the CIRCULATE-US Study in Colorectal Cancer

March 15th 2022

An overview of the design of the CIRCULATE-US study, set to further explore the potential of ctDNA testing in colorectal cancer.

EP. 11: Assessing the Full Potential of ctDNA in Colorectal Cancer

March 22nd 2022

Gregory P. Botta, MD, PhD, highlights key trials of interest exploring ctDNA analyses to better inform treatment decisions for patients with rectal cancers.

EP. 12: Investigating the Role of ctDNA in Colorectal Cancer: Next Steps

March 22nd 2022

Abstracts presented during ASCO GI 2022 and other initiatives in clinical trials, assessing treatment strategies for patients with colorectal cancer based on ctDNA negativity or positivity.

EP. 13: Incorporating ctDNA Into Routine Practice: Clinical Pearls

March 22nd 2022

Advice to GI oncologists in the community on using ctDNA testing to detect minimal residual disease and inform treatment decisions in colorectal cancer.